1. Home
  2. AIMD vs LTRN Comparison

AIMD vs LTRN Comparison

Compare AIMD & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ainos Inc.

AIMD

Ainos Inc.

SELL

Current Price

$1.24

Market Cap

10.6M

Sector

Health Care

ML Signal

SELL

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$0.25

Market Cap

10.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIMD
LTRN
Founded
1984
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
10.0M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
AIMD
LTRN
Price
$1.24
$0.25
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $17.50
AVG Volume (30 Days)
★ 4.0M
173.4K
Earning Date
11-16-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.65
EPS
N/A
★ N/A
Revenue
★ $124,157.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 498.95
N/A
52 Week Low
$0.43
$0.28
52 Week High
$3.88
$4.34

Technical Indicators

Market Signals
Indicator
AIMD
LTRN
Relative Strength Index (RSI) 60.79 19.28
Support Level $0.50 N/A
Resistance Level $1.75 $0.84
Average True Range (ATR) 0.30 0.08
MACD 0.08 -0.00
Stochastic Oscillator 51.47 3.01

Price Performance

Historical Comparison
AIMD
LTRN

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: